UBS Group »

Perspective Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.5M 926k 2.75
2025-09-30 $2.2M 641k 3.43
2025-06-30 $1.3M 373k 3.44
2025-03-31 $1.0M 470k 2.13
2024-12-31 $1.8M 572k 3.19
2024-09-30 $1.2M 86k 13.35
2024-06-30 $183k 18k 9.97